Home
>
Reference Standards>Environmental Reference Standards>Clinical Drug Reference Standards> Memantine Hydrochloride
For research use only. Not for therapeutic Use.
Memantine Hydrochloride(CAT: A000392) is an FDA-approved N-methyl-D-aspartate (NMDA) receptor antagonist widely used in neuropharmacological and clinical research. By modulating glutamatergic neurotransmission, it prevents excessive calcium influx and mitigates excitotoxicity, a key mechanism in neurodegenerative diseases. Memantine is best known as a therapeutic agent for moderate-to-severe Alzheimer’s disease, where it improves cognition and daily functioning. Beyond dementia, it is studied in models of Parkinson’s disease, stroke, neuropathic pain, and psychiatric disorders, offering broad neurological relevance. Its favorable safety profile and well-characterized pharmacokinetics make Memantine Hydrochloride a valuable reference compound for CNS drug development and excitotoxicity research.
CAS Number | 41100-52-1 |
Synonyms | 41100-52-1; Memantine HCL; 3,5-dimethyladamantan-1-amine hydrochloride; 3,5-Dimethyl-1-adamantanamine hydrochloride; Namenda |
Molecular Formula | C12H22ClN |
Purity | ≥95% |
Storage | Room temperature |
IUPAC Name | 3,5-dimethyladamantan-1-amine;hydrochloride |
InChI | 1S/C12H21N.ClH/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10;/h9H,3-8,13H2,1-2H3;1H |
InChIKey | LDDHMLJTFXJGPI-VXMZOEJHSA-N |
SMILES | CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |